LIVEPERSON INC (LPSN)

US5381461012 - Common Stock

0.8123  -0.03 (-3.3%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LPSN. LPSN was compared to 279 industry peers in the Software industry. Both the profitability and financial health of LPSN have multiple concerns. LPSN does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year LPSN has reported negative net income.
LPSN had a negative operating cash flow in the past year.
In the past 5 years LPSN always reported negative net income.
In multiple years LPSN reported negative operating cash flow during the last 5 years.

1.2 Ratios

LPSN has a Return On Assets of -12.46%. This is in the lower half of the industry: LPSN underperforms 63.44% of its industry peers.
Looking at the Return On Equity, with a value of -131.61%, LPSN is doing worse than 81.36% of the companies in the same industry.
Industry RankSector Rank
ROA -12.46%
ROE -131.61%
ROIC N/A
ROA(3y)-14.43%
ROA(5y)-14.54%
ROE(3y)-191.95%
ROE(5y)-136.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LPSN has a Gross Margin (66.99%) which is in line with its industry peers.
LPSN's Gross Margin has declined in the last couple of years.
LPSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.18%
GM growth 5Y-2.99%

1

2. Health

2.1 Basic Checks

LPSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LPSN has been increased compared to 1 year ago.
Compared to 5 years ago, LPSN has more shares outstanding
LPSN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -1.48, we must say that LPSN is in the distress zone and has some risk of bankruptcy.
LPSN's Altman-Z score of -1.48 is on the low side compared to the rest of the industry. LPSN is outperformed by 79.57% of its industry peers.
A Debt/Equity ratio of 7.04 is on the high side and indicates that LPSN has dependencies on debt financing.
The Debt to Equity ratio of LPSN (7.04) is worse than 88.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.04
Debt/FCF N/A
Altman-Z -1.48
ROIC/WACCN/A
WACC1.76%

2.3 Liquidity

LPSN has a Current Ratio of 1.36. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.36, LPSN perfoms like the industry average, outperforming 41.58% of the companies in the same industry.
LPSN has a Quick Ratio of 1.36. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
LPSN has a Quick ratio of 1.36. This is comparable to the rest of the industry: LPSN outperforms 41.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.28% over the past year.
The Revenue for LPSN has decreased by -21.91% in the past year. This is quite bad
The Revenue has been growing by 9.98% on average over the past years. This is quite good.
EPS 1Y (TTM)43.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.94%
Revenue 1Y (TTM)-21.91%
Revenue growth 3Y3.12%
Revenue growth 5Y9.98%
Sales Q2Q%-26.73%

3.2 Future

LPSN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.48% yearly.
The Revenue is expected to decrease by -9.39% on average over the next years.
EPS Next Y73.5%
EPS Next 2Y19.51%
EPS Next 3Y2.48%
EPS Next 5YN/A
Revenue Next Year-23.27%
Revenue Next 2Y-14.81%
Revenue Next 3Y-9.39%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LPSN. In the last year negative earnings were reported.
Also next year LPSN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.51%
EPS Next 3Y2.48%

0

5. Dividend

5.1 Amount

No dividends for LPSN!.
Industry RankSector Rank
Dividend Yield N/A

LIVEPERSON INC

NASDAQ:LPSN (11/21/2024, 3:01:53 PM)

0.8123

-0.03 (-3.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap72.31M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.46%
ROE -131.61%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 66.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 7.04
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)43.28%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y73.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-21.91%
Revenue growth 3Y3.12%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y